Capital Fund Management S.A. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Capital Fund Management S.A.

  • $33.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$29.01 - $74.23 $206,406 - $528,146
-7,115 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$27.51 - $57.29 $195,733 - $407,618
7,115 New
7,115 $242,000
Q3 2019

Nov 13, 2019
SELL
$37.38 - $49.47 $441,084 - $583,746
-11,800 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$39.79 - $67.01 $469,522 - $790,718
11,800 New
11,800 $517,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email